Neoadjuvant therapy of cetuximab combined with chemoradiotherapy in rectal cancer: A single-arm meta-analysis of noncomparative clinical studies and randomized controlled trials

OBJECTIVE: Preoperative chemoradiotherapy combined with radical resection has reduced local recurrence rates in rectal cancer. Cetuximab shows improvement in rectal cancer treatment. But the role for neoadjuvant therapy of cetuximab combined with chenmoradiotherapy in rectal cancer remains unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Qi, Zhu, Jun-jing, Zhao, Fang-min, Shu, Qi-jin, Chen, Shu-yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899853/
https://www.ncbi.nlm.nih.gov/pubmed/33607800
http://dx.doi.org/10.1097/MD.0000000000024649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899853/
https://www.ncbi.nlm.nih.gov/pubmed/33607800
http://dx.doi.org/10.1097/MD.0000000000024649

Ejemplares similares